Founded in 2013, Kleinmuntz Associates is a closely-held venture capital firm based in Chicago.  Our emphasis is on analytics and biotechnology focused on cancer care.  We work with very early stage startup companies using an approach that combines angel capital investment with business advisory services.





Dr. Catherine Kleinmuntz is Principal at Kleinmuntz Associates and is co-Executive Director of the Kleinmuntz Family Foundation, where she focuses on philanthropy. Dr. Kleinmuntz currently provides strategic consulting services to several biotechnology start-up companies and works with several non-profit groups.
Dr. Kleinmuntz spent more than three decades working in healthcare. After earning a B.A. in Biological Sciences at the University of Chicago, she continued her graduate studies, earning an M.A. and Ph.D. from the University of Chicago's School of Social Service Administration prior to becoming a practicing psychotherapist.
Catherine quickly transitioned into healthcare administration, before becoming a consultant at Kaufman Hall and Associates. While working at Kaufman Hall, she earned an MBA from the University of Chicago's Booth School of Business with dual concentrations in finance and hospital administration. She consulted with numerous hospitals and large healthcare systems in financial advisory engagements and assumed sole responsibility for Kaufman Hall's software operations, rising to the rank of Vice President.

In 1996, Drs. Catherine and Don Kleinmuntz founded Strata Decision Technology. Starting in the basement of their home in Champaign, they grew the company into a leading provider of financial analytics software solutions for the healthcare industry. Catherine was President and CEO until the company was sold to a private equity firm in 2011, continuing as an Executive Advisor for the next several years. As CEO, she set strategic direction for the company and the products, built the management team, and was heavily involved in sales and business development. Catherine maintained collaborative relationships with the senior executives at many of the largest and most sophisticated healthcare organizations in the US. Under Catherine's leadership, Strata grew to become an industry-leading source of financial analytics solutions for healthcare provider organizations, with software implemented at nearly one third of major US hospitals. Strata is currently a subsidiary of Roper Technologies, a publicly held corporation, and their products are consistently rated as category leaders in financial decision support software by independent rating services.



Empowering Precision Cancer Care

Simbiosys is a technology company on a mission to deploy Computational Oncology to transform decision making and patient experience in Cancer Care. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options to truly individualize treatment. The company was founded in 2018 at the University of Illinois at Urbana-Champaign.


©2019 by Kleinmuntz Associates LLC. Proudly created with Wix.com